PER
Click for more information
1.19% 8.5¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says FDA lifts hold for multiple sclerosis drug study

  1. Hot News
    189,552 Posts.
    lightbulb Created with Sketch. 2781
    clock Created with Sketch.
    02/10/17
    10:15
    Post #: 27589158

    Oct 2 (Reuters) - Antisense Therapeutics Ltd (ANP) :

    • Advised by FDA that full clinical hold for phase IIb clinical study of ATL1102 for multiple sclerosis has been lifted
    • Co's application to conduct clinical trial of ATL1102 has been approved by Human Research Ethics Committee
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS From the Floor: Gold questions answered...
right-arrow Created with Sketch.
GT1 Green Technology hands the helm to Henry
right-arrow Created with Sketch.
EMD Emyria's Empax Centre chosen for mental health clinical trial
right-arrow Created with Sketch.
NEWS Week 24 Wrap: US contagion sentiment not so contagious; iron ore remains pressured
right-arrow Created with Sketch.
NEWS Hillcrest Partners with Ocean Batteries to Deploy ZVS Invert
right-arrow Created with Sketch.
NEWS Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢ 		Change
0.001(1.19%) 		Mkt cap ! $76.63M
Open High Low Value Volume
8.5¢ 8.5¢ 8.5¢ $2.708K 31.85K

Buyers (Bids)

No. Vol. Price($)
2 77428 8.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 119843 1
View Market Depth
Last trade - 14.29pm 20/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.